We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
+16.84%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$5.13B
AUM Growth
-$201M
Cap. Flow
+$55.7M
Cap. Flow %
1.09%
Top 10 Hldgs %
88.73%
Holding
94
New
14
Increased
25
Reduced
6
Closed
34

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$30.9M
2
CELG
Celgene Corp
CELG
+$26.8M
3
BAC icon
Bank of America
BAC
+$13.5M
4
APTV icon
Aptiv
APTV
+$12M
5
C icon
Citigroup
C
+$10.4M

Top Sells

Rank Stock Value
1
LNKD
LinkedIn Corporation
LNKD
+$22.5M
2
YUM icon
Yum! Brands
YUM
+$21.9M
3
MBLY
Mobileye N.V.
MBLY
+$14.8M
4
GM icon
General Motors
GM
+$13.6M
5
V icon
Visa
V
+$13.6M

Sector Composition

Rank Sector Weight
1 Consumer Staples 57.56%
2 Healthcare 19.57%
3 Miscellaneous 10.94%
4 Consumer Discretionary 9.33%
5 Financials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
51
DELISTED
ChemoCentryx, Inc.
CCXI
$2.24M 0.04%
900,000
– –
DMTX
52
DELISTED
Dimension Therapeutics, Inc
DMTX
$2.15M 0.04%
275,000
+100,000
+57% +$788K
GLPI icon
53
Gaming and Leisure Properties
GLPI
$11.9B
$2.1M 0.04%
+70,000
New +$1.9M
AGEN
54
CALL
Agenus
AGEN
$312M
$2.08M 0.04%
+25,475
New +$1.72M
IBRX icon
55
ImmunityBio
IBRX
$8.47B
$1.85M 0.04%
225,000
– –
RGNX icon
56
Regenxbio
RGNX
$522M
$1.73M 0.03%
160,000
– –
PARN
57
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.06M 0.02%
500,000
– –
IMDX
58
Insight Molecular Diagnostics
IMDX
$124M
$296K 0.01%
+3,205
New +$284K
CERE
59
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$225K ﹤0.01%
1,024,020
– –
CLCD
60
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$35K ﹤0.01%
5,575
– –
BABA icon
61
CALL
Alibaba
BABA
$273B
– –
-300,000
Closed -$24.4M
BLUE
62
CALL
DELISTED
bluebird bio
BLUE
– –
-3,860
Closed -$3.21M
BMRN icon
63
CALL
BioMarin Pharmaceuticals
BMRN
$12.5B
– –
-100,000
Closed -$10.5M
BMY icon
64
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-500,000
Closed -$34.4M
GE icon
65
CALL
GE Aerospace
GE
$320B
– –
-104,331
Closed -$15.6M
GILD icon
66
CALL
Gilead Sciences
GILD
$181B
– –
-300,000
Closed -$30.4M
GM icon
67
CALL
General Motors
GM
$74.5B
– –
-1,000,000
Closed -$34M
GM icon
68
General Motors
GM
$74.5B
– –
-400,000
Closed -$13.6M
IBB icon
69
CALL
iShares Biotechnology ETF
IBB
$10.3B
– –
-300,000
Closed -$33.8M
INCY icon
70
CALL
Incyte
INCY
$24.6B
– –
-50,000
Closed -$5.42M
IONS icon
71
CALL
Ionis Pharmaceuticals
IONS
$8.01B
– –
-100,000
Closed -$6.19M
HAPN
72
CALL
Happen Inc
HAPN
$1.88B
– –
-65,000
Closed -$3.59M
MRK icon
73
CALL
Merck
MRK
$354B
– –
-524,000
Closed -$26.4M
MS icon
74
CALL
Morgan Stanley
MS
$316B
– –
-1,000,000
Closed -$31.8M
MU icon
75
CALL
Micron Technology
MU
$1.04T
– –
-1,000,000
Closed -$14.2M
1 2
3
4

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q1 2016 Portfolio in Review

As of Q1 2016, Artal Group held 94 positions worth $5.13B, down 3.8% from $5.33B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Artal Group's Q1 2016 filing shows 14 new, 25 increased, 6 reduced and 34 closed positions. Its largest new stake was Goldman Sachs: 200,000 shares worth $31.4M. The largest sale was LinkedIn Corporation, an estimated $22.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 58% of assets, up from 40% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Artal Group's largest Q1 2016 buy was Goldman Sachs: 200,000 shares worth $31.4M.
  • Artal Group added most to Celgene Corp in Q1 2016, an estimated $26.8M increase.
  • Artal Group's biggest Q1 2016 reduction was Mastercard, cutting an estimated $8.84M.
  • Artal Group fully exited LinkedIn Corporation in Q1 2016, selling an estimated $22.5M.
  • Artal Group's ten largest holdings make up 89% of its $5.13B portfolio in Q1 2016.
  • Artal Group opened 14 new positions and closed 34 in Q1 2016.
  • Artal Group's portfolio value fell 3.8% quarter-over-quarter to $5.13B.

Based on Artal Group's 13F filing for Q1 2016, filed 12 May 2016.